Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
94.81
-0.50 (-0.52%)
At close: Jun 26, 2026, 4:00 PM EDT
94.81
0.00 (0.00%)
After-hours: Jun 26, 2026, 4:31 PM EDT
Inhibrx Biosciences Employees
As of December 31, 2025, Inhibrx Biosciences had 110 total employees, including 109 full-time and 1 part-time employees. The number of employees decreased by 51 or -31.68% compared to the previous year.
Employees
110
Change (1Y)
-51
Growth (1Y)
-31.68%
Revenue / Employee
$11,818
Profits / Employee
-$1,183,500
Market Cap
1.39B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 110 | -51 | -31.68% |
| Dec 31, 2024 | 161 | -11 | -6.40% |
| Dec 31, 2023 | 172 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Novavax | 749 |
| Immatics | 678 |
| Maravai LifeSciences Holdings | 416 |
| Zenas BioPharma | 167 |
| Maze Therapeutics | 141 |
| MapLight Therapeutics | 133 |
| MoonLake Immunotherapeutics | 130 |
| ArriVent BioPharma | 77 |
INBX News
- 11 days ago - Inhibrx announces FDA acceptance of BLA for ozekibart - TheFly
- 11 days ago - Inhibrx Announces U.S. FDA Acceptance of BLA for Ozekibart in Patients with Conventional Chondrosarcoma - PRNewsWire
- 6 weeks ago - Inhibrx price target raised to $325 from $300 at Stifel - TheFly
- 6 weeks ago - Inhibrx Reports First Quarter 2026 Financial Results - PRNewsWire
- 6 weeks ago - Inhibrx Biosciences Quarterly report: Q1 2026 - Filings
- 6 weeks ago - Inhibrx’s INBRX-106 shows potential benefit in HNSCC - TheFly
- 6 weeks ago - Inhibrx Biosciences Transcript: Study update - Transcripts
- 6 weeks ago - Inhibrx Biosciences Press release: Study update - Filings